Clinical Trial Update: Maribavir for Prevention of CMV After Stem Cell Transplants [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for maribavir in preventing CMV after stem cell transplant has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• Maribavir (maribavir)

Snippet

Sponsor: Shire | Conditions: Cytomegalovirus Infection | Phase 2 | Status: COMPLETED